AKT1 and viral infectious disease: In contrast to the canonical paradigm, Gefitinib did not show inhibitory effects on the activation of Akt attributed to virus infection (Figure 8), an indicator of PI3K activity, suggesting that EGFR signaling is not the exclusive upstream activator of the PI3K/Akt cascade in the context of virus infection.